1,771
Views
2
CrossRef citations to date
0
Altmetric
Review

In vivo assay and modelling of protein and mitochondrial turnover during aging

&
Pages 60-72 | Received 13 Feb 2021, Accepted 26 Mar 2021, Published online: 18 May 2021

Figures & data

Figure 1. Overview of methods for calculating protein half-life in cells and organisms

Common to each approach is marking a pool of protein to enable assay of decay rate. Half-life is calculated by fitting the data to the equation for exponential decay. In each plot, time is indicated on the X-axis and protein abundance on the Y-axis, in arbitrary units. (A) Cycloheximide block of protein synthesis. (B) Heavy-isotope labelling (continuous). (C) Photobleach of fluorescent protein. (D) Green-to-red photoconversion. (E) SNAP-tag labelling. (F) Conditional gene expression. In this example, conditional gene expression is activated by a drug, administered for a brief time interval as indicated below the plot. The red curve indicates the rate of production of the protein, and the blue curve indicates the abundance of the protein.
Figure 1. Overview of methods for calculating protein half-life in cells and organisms

Figure 2. Fluorescent protein synthesis and turnover in free-moving adult Drosophila. (a) Neuronal expression of eGFP. The tissue-general Actin-Gene-Switch[255B] driver strain [Citation87] was crossed to the multi-copy UAS-eGFP strain (‘ultra-GFP’ [Citation29]), and six male progenies were placed in a glass vial with media supplemented with 160 μg/ml mifepristone (RU486). GFP fluorescence was quantified continuously using video and FluoreScore software, and is expressed in relative units (figure adapted from [Citation111]). Light green indicates average GFP intensity per minute and dark green is the LOESS curve. (b) Decay rate of GFP targeted to the mitochondrial matrix. mitoGFP is a mitochondria-targeted form of eGFP created by fusing the human COX VIII mitochondrial targeting signal to the N terminus of eGFP [Citation113]. In a proof-of-principle experiment, the tissue-general Actin-Gene-Switch[255B] driver strain was crossed to the UAS–mitoGFP[AP3] strain [Citation113], and male progeny (1–5 days of age) were placed in vials with media supplemented with 160 μg/ml mifepristone (RU486) or on control media. After 48 hours, all flies were transferred to glass culture vials with control media, at 6 flies per vial, using three replicate vials for drug treated flies and three replicate vials for controls (time 0). The flies were then assayed for GFP fluorescence at the indicated time points using 4 minute videos and FluoreScore software, and the average and SD of the three vials is plotted for each of (-) drug and (+) drug groups. The data suggests an in vivo half-life for mitoGFP of ~3 days

Figure 2. Fluorescent protein synthesis and turnover in free-moving adult Drosophila. (a) Neuronal expression of eGFP. The tissue-general Actin-Gene-Switch[255B] driver strain [Citation87] was crossed to the multi-copy UAS-eGFP strain (‘ultra-GFP’ [Citation29]), and six male progenies were placed in a glass vial with media supplemented with 160 μg/ml mifepristone (RU486). GFP fluorescence was quantified continuously using video and FluoreScore software, and is expressed in relative units (figure adapted from [Citation111]). Light green indicates average GFP intensity per minute and dark green is the LOESS curve. (b) Decay rate of GFP targeted to the mitochondrial matrix. mitoGFP is a mitochondria-targeted form of eGFP created by fusing the human COX VIII mitochondrial targeting signal to the N terminus of eGFP [Citation113]. In a proof-of-principle experiment, the tissue-general Actin-Gene-Switch[255B] driver strain was crossed to the UAS–mitoGFP[AP3] strain [Citation113], and male progeny (1–5 days of age) were placed in vials with media supplemented with 160 μg/ml mifepristone (RU486) or on control media. After 48 hours, all flies were transferred to glass culture vials with control media, at 6 flies per vial, using three replicate vials for drug treated flies and three replicate vials for controls (time 0). The flies were then assayed for GFP fluorescence at the indicated time points using 4 minute videos and FluoreScore software, and the average and SD of the three vials is plotted for each of (-) drug and (+) drug groups. The data suggests an in vivo half-life for mitoGFP of ~3 days

Data availability statement

The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.